A new report co-authored by Manhattan Institute senior fellow Benjamin Zycher, and Joseph DiMasi, and Christopher-Paul Milne, researchers from the Tufts Center for the Study of Drug Development, examines case histories for thirty-five important pharmaceutical innovations.

China has unveiled a set of guidelines that outline when the death penalty can be applied to the producers or sellers of fake drugs.

More than half of all medicines and common chemicals are made from naturally occurring resources. And a recent national survey of more than 1,000 Australians found there is surging support for the modern manipulation of nature referred to as biotechnology.

A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline

Microsoft Office SharePoint Portal Server 2003 and Interse iBox solution help pharmaceutical company enable more relevant searches for improved decision-making.